Nothing said here yet.
to join the conversation.
| April McClain Delaney | Sell | $175.0K | Tue, Aug 25 | Tue, Sep 1 |
| Thomas H Tuberville | Sell | $8.0K | Fri, May 3 | Wed, Aug 5 |
| Alan Armstrong | Buy | $8.0K | Fri, Mar 27 | Tue, Jul 21 |
| April McClain Delaney | Sell | $8.0K | Fri, Apr 17 | Fri, May 1 |
| Jared Moskowitz | Sell | $8.0K | Mon, Mar 23 | Tue, Mar 31 |
Brown & Brown’s third quarter results drew a negative market reaction as the company missed Wall Street expectations on both revenue and non-GAAP profit.
Key TakeawaysBrown & Brown shares fell 5% after third-quarter revenue of $1. 7 billion missed the $1.
Shares of insurance brokerage firm Brown & Brown (NYSE:BRO) fell 4.9% in the afternoon session after the company reported slowing organic revenue growth and margin compression in its third-quarter 2026 financial results.
Its latest quarterly earnings report wasn't greeted warmly by the market.
Brown & Brown reported Q3 2026 revenue of US$1.73b and net income of US$240m, with earnings per share coming in slightly below Wall Street expectations and organic revenue growth remaining modest.
Brown & Brown (NYSE:BRO) reported third-quarter revenue of $1.7 billion, up 7.4% from a year earlier, as improvement in its retail business helped offset pressure in specialty distribution operations.
Accession integration gains offset Specialty Distribution headwinds as synergy targets rise.
Brown & Brown (BRO) is back in focus after its third quarter 2026 results, with revenue of US$1.73b and modest organic growth, falling short of consensus expectations on both sales and earnings.
Brown & Brown's Q3 revenue growth is supported by acquisitions, but weak organic growth, softer specialty markets and margin pressure weigh on results.
Moby summary of Brown & Brown, Inc.'s Q3 2026 earnings call